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ABSTRACT 
 
Assembly of DNA into chromatin allows for the formation of a barrier that protects naked DNA from protein and chemical agents 
geared to degrade or metabolize DNA. Chromatin assembly occurs whenever a length of DNA becomes exposed to the cellular 
elements, whether during DNA synthesis or repair. This report describes tools to study chromatin assembly in the model system 
Saccharomyces cerevisiae. Modifications to an in vitro chromatin assembly assay are described that allowed a brute force screen of 
temperature sensitive (ts) yeast strains in order to identify chromatin assembly defective extracts. This screen yielded mutations in genes 
encoding two ubiquitin protein ligases (E3s): RSP5, and a subunit of the Anaphase Promoting Complex (APC), APC5. Additional 
modifications are described that allow for a rapid analysis and an in vivo characterization of yeast chromatin assembly mutants, as well as 
any other mutant of interest. Our analysis suggests that the in vitro and in vivo chromatin assembly assays are responsive to different 
cellular signals, including cell cycle cues that involve different molecular networks. 
 
 
INTRODUCTION 
 
DNA is the most evolutionarily conserved molecule. Most, but 
not all systems that encode proteins, from viruses and bacteria to 
higher eukaryotes, do so by interpreting the information stored 
within DNA. It is therefore no surprise to learn that virtually all 
proteins that interact with DNA, such as histones for example, 
are also highly conserved evolutionarily. Recent studies have 
shown that the interaction between histones and DNA, to form 
chromatin, are extremely dynamic and serve as a platform for 
post-translational modifying activities, such as acetylation, 
phosphorylation, methylation and ubiquitination (1, 2). In the 
absence of proper assembly, regulation and maintenance of 
chromatin, the cell will most likely die due to misregulated 
transcriptional control or defects in chromosome folding and 
packaging. 
 
Chromatin is made up of segments of approximately 146 
basepairs of DNA wrapped around a complex of eight proteins 
made up of two copies of the four histones, H2A, H2B, H3 and 
H4 (3, 4). This complex is also known as the nucleosome. 
Chromatin assembly is initiated by a tetramer of two H3 
molecules and two H4 molecules, which interact with naked 
DNA with the aid of chromatin assembly factors. Two 
H2A/H2B dimers are then delivered to the H3/H4/DNA 
complex by other chromatin assembly factors to complete the 
nucleosome (5). In vitro biochemical studies have demonstrated 
that histones incorporated into chromatin are acetylated and that 
once assembled, the chromatin is matured by the removal of the 
acetyl groups (6, 7). Deacetylation of newly assembled histones is 
generally believed to play an important role in the establishment 
of heterochromatin (reviewed in 4). Subsequent action by a host 
of histone modifying activities direct transcription, replication, Harkness et al.    
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DNA repair, chromosome condensation and decondensation, 
and ultimately, cell cycle progression (8-10). 
 
To understand chromatin assembly at a molecular level an in vitro 
chromatin assembly assay was developed that relied on a simple 
plasmid supercoiling assay and a yeast whole-cell extract (11). We 
showed that this assay depended on ATP, acetylatable histone 
tails and was cell cycle regulated (11-15). The use of this system 
lead to a genetic screen aimed at identifying factors involved in 
chromatin assembly. This resulted in the discovery of the 
ubiquitin system as a major player in regulating chromatin 
assembly (15).  
 
The ubiquitin targeting system relies on three classes of proteins 
to select and ubiquitinate proteins: a ubiquitin-activating protein 
(E1), one of a family of ubiquitin-conjugating proteins (E2), and 
one of a structurally and functionally distinct family of ubiquitin-
protein ligases (E3; 16). Our studies revealed that the E3 
enzymes, Rsp5p and the Anaphase Promoting Complex (APC), 
are required for an in vitro chromatin assembly activity that is 
most active during mitosis (14, 15). The discovery of both Rsp5p 
and the APC in our screen presented an interesting challenge. 
For example, Rsp5p, a single polypeptide activity, is localized to 
the plasma membrane and adjacent to vacuoles (17, 18), whereas 
the APC, an evolutionarily conserved complex of at least 13 
proteins, functions within the nucleus (19, 20). Furthermore, 
Rsp5p is involved in mitochondrial biogenesis (21, 22), plasma 
membrane protein turnover, endocytosis, transcription and 
recombination (reviewed in 23), while the main function of the 
APC is believed to be the targeting of proteins that inhibit 
mitotic progression and exit for degradation (24, 25). It is 
possible that the identification of Rsp5p and the APC in our 
screen reflects the existence of a signaling cascade controlling 
chromatin assembly that connects extracellular signals with 
chromatin metabolism. 
 
In this report, we describe in detail the methods we utilized to 
study chromatin assembly, both in vitro and in vivo. These 
methods allowed us to carry out a brute force genetic screen that 
resulted in the isolation of chromatin assembly mutants in yeast. 
Furthermore, we describe additional modifications to these 
assays that can be used to screen for additional chromatin 
assembly mutants or characterize existing mutants that may play 
a role in chromatin metabolism. 
 
MATERIALS AND METHODS 
 
Yeast strains and culture media 
 
The yeast strains used in this study are shown in Table 1. The 
H1G4 strain (YTH335) contains the mutations rmc1/apc5
CA, rmc2 
and rmc3/rsp5
P-S (15). Cells were cultured in the media indicated: 
YPD (1% yeast extract, 2% peptone and 2% glucose [Difco]) and 
YPGal (1% yeast extract, 2% peptone and 2% galactose). 
Hydroxyurea (Sigma) was added to cells growing in YPD to a 
final concentration of 0.3 M. Methods for preparing yeast cells 
for FACS scan analysis have been described previously (26). 
 
Table 1: Yeast strains used in this study 
Strain  Genotype Source 
RMY102  MATa ade2-101 his3-∆200 lys2-801 
trp1∆901 ura3-52 hht1 hhf1::LEU2 
hht2 
hhf2::HIS3 + pRM102 
(CEN/URA3 GAL10prom-HHT2 
Gal1prom-HHF2) 
M. Grunstein 
(12, 31) 
S288c derivatives 
YTH3  MATα ade2 leu2-3,112  lys2∆201 
ura3-52 
(15) 
YTH6  MATa ade2 his3∆200 lys2∆201 
ura3-52 
(15) 
YTH1235  MATa ade2 his3∆200  leu2-3,112  
lys2∆201 ura3-52 
YTH3 x 
YTH6 
YTH1155  MATα ade2 his3∆200 leu2-3,112 
lys2∆201(?) ura3-52 apc5
CA-
PA::His5
+ 
(15) 
A354a derivatives 
YTH83  MATa ade1 ade2 gal1 his7 lys2 tyr1 
ura1 
M. Winey 
H1F1-
H1G6 
isogenic to A364a  Hartwell ts 
library (27) 
YTH335 
(H1G4) 
MATa ade1 ade2 gal1 his7 lys2 tyr1 
ura1 rmc1-1 rmc2 rmc3-1 
(15) 
 
Whole-cell extract preparation  
 
“Noodle” preparation 
 
For the screen presented in this report, one hundred strains were 
chosen at random for extract preparation from the Hartwell 
collection of temperature sensitive (ts) strains (27). Extract 
preparations involve three main steps: i) generation of frozen 
“noodles,” ii) grinding of the “noodles,” and iii) 
ultracentrifugation of the ground powder. To prepare yeast 
“noodles,” strains of interest are picked from glycerol stocks 
stored at -80°C and grown on YPD plates. Fresh colonies from 
these plates are then grown in 10 ml YPD and used to inoculate 
500 ml YPD cultures. The cultures, usually grown in batches of 
six (the ultracentrifuge rotor holds 6 samples), are shaken at room 
temperature until an OD600 o f  3 . 0  i s  r e a c h e d ,  t h e n  s h i f t e d  t o  
37°C for two hours. The cells are then harvested by 
centrifugation at 4,000 rpm for 5 minutes. All supernatant is 
removed and the mass of the cell pellet is determined. The cells 
are then washed, in succession, with i) 10 ml H2O, ii) 10 ml YEB 
(yeast extract buffer; 1 mM EDTA, 5 mM EGTA and 100 mM 
HEPES pH 7.9), and iii) 1.3 x volume/cell mass YEB plus a 
protease inhibitor cocktail (0.2 mM PMSF, 10 mM Benzamidine-
HCl, 25 µg/ml TPCK, 5 µg/ml leupeptin, 3.5 µg/ml pepstatin 
and 10 µg/ml aprotinin) and 2.5 mM DTT. The protease 
inhibitors are purchased from Sigma. All buffers are kept at 4°C 
and the protease inhibitor cocktail is diluted fresh from frozen Harkness et al.    
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stocks (200 mM PMSF in isopropanol [kept at room 
temperature], 1 M Benzamidine in H2O, 3 mg/ml TPCK in 
ethanol, 1 mg/ml leupeptin in H2O, 1 mg/ml pepstatin in 
methanol, 2 mg/ml aprotinin in 0.1% NaCl and 1M DTT in 10 
mM NaAc pH 6). The final yeast pellets are then loaded into 10 
ml syringes that are pre-cooled in a 4°C cold room. The yeast 
filled syringes are then extruded into 50 ml Falcon tubes filled 
with liquid nitrogen. The yeast “noodles” can then be stored at -80°C 
indefinitely. 
 
Whole-cell yeast extract preparation from a library 
of ts yeast cells 
 
We generally prepare extracts from the yeast “noodles” in 
batches of six. The entire process is best carried out in a cold 
room. To begin, 2.5 g of frozen “noodles” (fragmented by 
shaking) are added to 250 ml beakers that are pre-cooled on dry 
ice for weighing purposes. The “noodle” fragments are then 
added to coffee mills (standard coffee mills purchased at any 
home hardware store) that are pre-cooled with ground dry ice 
pellets. Dry ice is added to the coffee mills so that the ground 
powder just covers the mill blades. The yeast “noodle”/dry ice 
powder mixture is ground for 5 minutes. When the grind is 
finished the mills are quickly turned upside down to gather the 
ground yeast powder in the cap. This also avoids thawing the 
yeast in the rapidly warming coffee mills. The yeast powder is 
then scooped into the 250 ml beakers (which should be at 4°C), 
the remaining dry ice powder is dissipated and 1.3 x 
volume/mass YEB plus protease inhibitor cocktail and DTT is 
added. A suspension of YEB and yeast powder is then made by 
pipetting. The remaining yeast powder on the beaker walls can be 
washed in this manner. The mixture is added to cooled 
ultracentrifugation tubes (Beckman) and the weight of each tube 
is determined to ensure opposed tubes are perfectly balanced. 
Unbalanced tubes can be equilibrated by the additional of 
mineral oil to the lighter tube. The balanced tubes are loaded into 
a cooled ultracentrifuge rotor (SW55Ti) and spun for 2 hours at 
27,000 rpm (100,000 x g). In our hands, extracts prepared from 
samples where a low speed spin was used rather than a high 
speed spin were unsuccessful. 
 
During the ultracentrifugation, a 50X volume of YDB/volume of 
total extract is prepared (yeast dialysis buffer; 20 mM HEPES pH 
7.9, 0.05 mM EDTA, 5 mM EGTA, 20% glycerol, 2.5 mM DTT, 
0.2 mM PMSF and 0.5 µg/ml leupeptin) and stored at 4°C with a 
gently spinning stir bar. Dialysis tubing (MWCO: 6-8,000; 
Spectrum Laboratories, Inc.) is prepared by cutting strips of 
approximately 6 inches for each sample. One end of the tubing is 
folded over and clamped, and then the tubing is added to the 
YDB until the ultracentrifuge spin is complete. At the end of the 
spin the whole-cell protein extract is removed by tube puncture. 
The soluble protein sediments between a pellet composed of 
cellular debris layered with genomic DNA and a top layer 
consisting of lipids. A needle (22G x 1”; Terumo Medical Corp., 
Elkton, MD) attached to a 5 ml syringe is typically used to 
carefully puncture the tube just above the cell debris pellet. The 
soluble protein is removed and added to the cooled dialysis 
tubing. The free end of the dialysis tubing is clamped and the 
extract dialyzed against YDB at 4°C for at least 3 hours. At the 
end of the dialysis, the extract is added to microfuge tubes in 50-
100 µl aliquots on ice. The microtubes are then flash frozen in 
liquid nitrogen and stored at -80°C indefinitely. 
 
Genetic screen for chromatin assembly mutants 
 
Chromatin assembly reactions were performed on extracts 
prepared from temperature sensitive (ts) strains according to 
previously published protocols (11, 15). Here, we describe 
modified protocols that allowed the in vitro assay to be combined 
with a brute force genetic screen.  
 
32P-labeled plasmid DNA preparation 
 
In a typical chromatin assembly reaction, 20-100 µg of whole-cell 
extract protein is incubated with 20 ng of uniquely labeled 
circular, relaxed pBluescript (pBS) plasmid. The labeled probe is 
prepared by digesting 25 µg of pBS with HindIII in a 50 µl 
reaction. The terminal phosphates from the HindIII digested pBS 
are removed by calf intestinal phosphatase (CIP) treatment; 50 µl 
HindIII/pBS, 20 µl 10X CIP buffer, 2.5 µl CIP (New England 
BioLabs) and 128 µl H2O are incubated at 37°C for 1 hour. The 
DNA is then precipitated by the addition of 20 µl 3 M NaAc, pH 
4.8, and 500 µl 95% ethanol. The mixture is incubated at -80°C 
for 15 minutes, centrifuged for 10 minutes, and the dried pellet 
resuspended in 1X TE (10 mM Tris-HCl pH 8.0, 1 mM EDTA 
pH 8.0) at a concentration of 0.25 µg/µl. The HindIII digested 
pBS is end-labeled by incubating 0.5 ug (in 2 µl) of linear plasmid 
with 7.5 µl of 32P-γ-ATP (10 µCi/µl), 1.2 µl of 10X T4 
polynucleotide kinase buffer and 1 µl of T4 polynucleotide kinase 
(New England BioLabs). The reaction is incubated at 37°C for 
one hour and then added to a 500 µl ligation reaction containing 
the 12 µl kinase reaction, 50 µl 10X T4 ligase buffer and 3 µl T4 
ligase (New England BioLabs). The ligation reaction is continued 
overnight at 16°C. The next day, ligated, and uniquely labeled 
pBS is purified by chloroform/phenol and chloroform 
extraction. The top layer of each extraction (500 µl) is kept and 
67 µl of 5 M NH2SO4 is added following the extractions. The 
mixture is split into two tubes and the probe is precipitated by 
the addition of 95% ethanol (800 µl) to each tube. The 
precipitated “hot” DNA is pelleted and resuspended in a total of 
25 µl H2O (20 ng/µl). A 50 µl “hot/cold” mix is then prepared 
by mixing 5 µl of 32P labeled “hot” pBS with 400 ng (100 ng/µl) 
of a “cold”, relaxed, circular DNA preparation in H2O. “Cold” 
relaxed DNA is prepared by treating 50 µg of supercoiled pBS 
with 50 units of topoisomerase I in a 100 µl reaction, which is 
incubated at 37°C for 1.5 hours. The relaxed “cold” DNA is 
precipitated as described above and resuspended in a total of 500 
µl H2O. All DNA preparations are stored at -20°C. 
 
In vitro chromatin assembly reactions and analysis 
 
A typical chromatin assembly reaction is composed of 2 µl 
“hot/cold” DNA, 1 µl ATP (from a 60 mM stock in H2O pH 
7.5; Sigma), 1 µl creatine kinase (from a 2 µg/ml stock in 1 mM 
Tris-HCl pH 7.5; Sigma), 1 µl phosphocreatine (from a 400 mM 
stock in 1 mM Tris-HCl pH 7.5; Sigma) and 2 µl CAB (10 X Harkness et al.    
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chromatin assembly buffer; 75 mM MgCl2, 10 mM DTT and 0.5 
mM EDTA) for a total of 7 µl, which is then brought up to 20 µl 
as follows. For each whole-cell extract, the volume required for 
20-100 µg protein is calculated, with the balance made up with 
YDB. The final volume of 20 µl therefore consists of a 7 µl 
cocktail mix plus a 13 µl mix of YDB and protein extract. The 
extract is added after the YDB. The reaction tubes are kept on 
ice during this entire process. Once the extract is added, the 
reactions are incubated at 30°C for 30-60 minutes. The reactions 
are stopped by the addition of 200 µl of stop buffer (0.3 M NaAc 
pH 6.0, 0.5% SDS and 10 mM EDTA). The assembled template 
is extracted by the addition of 200 µl phenol/chloroform, and 
precipitated by the addition of 500 µl 95% ice-cold ethanol. The 
precipitated DNA pellet is dried and resuspended in 10 µl of 1X 
DNA loading dye. The samples are then separated through a 
large 0.8% agarose gel (13 x 25 cm; Owl) run overnight at 70 
volts in 1X TAE (50X stock: 242 g/L Tris base, 57.1 ml/L glacial 
acetic acid, 100 ml/L 0.5 M EDTA pH 8.0). The next morning 
the gel is stained in ethidium bromide, photographed and dried 
on a standard gel drier (Labconco; VWR). The dried gel is 
exposed to X-ray film (Kodak) overnight and developed the next 
day. Extracts found to be defective for in vitro chromatin 
assembly are repeated at least 3 times, from both heat shocked 
and non-heat shocked ts mutants. Extracts found to be defective 
in all three trials are deemed to be true chromatin assembly 
mutants. Assembly efficiency is found to be variable between 
independent extracts and between individual reactions with the 
same extract. Therefore, at least three independent reactions are 
performed with each extract. A sample of chromatin assembly 
run on 18 extracts prepared from the Hartwell ts strains is shown 
in Figure 1. Characterization of the H1G4 (YTH335) strain has 
been reported (15). 
 
 
Fig. 1: A brute force genetic screen for in vitro chromatin assembly 
mutants in yeast. Whole-cell extracts were prepared from yeast strains randomly 
selected from a library of temperature sensitive (ts) mutants (27). 100 µg of extract 
protein was incubated with uniquely labeled circular relaxed plasmid DNA in the 
presence of an ATP regeneration system. Following the reaction, the intermediate 
DNA topoisomers (int.) were resolved, together with the open, relaxed (O, R) 
and supercoiled (sup.) species, through a 0.8% agarose gel. An extract is deemed 
to be defective if an accumulation of intermediate topoisomers is observed. One 
extract, H1G4, was found to be unable to fully supercoil the input plasmid 
(compare the accumulation of intermediate topoisomers to completely 
supercoiled bands). 
 
Non-radioactive in vitro chromatin assembly 
 
The whole-cell extract preparation described above also supports 
in vitro chromatin assembly in the presence of non-radioactive 
probe DNA. Typically, 100-200 ng circular, relaxed pBS (relaxed 
by topoisomerase treatment described above) is incubated with 
150-200 µg protein extract (see above for description of extract 
preparation). The reaction is generally performed in a final 
volume of 40 µl to accommodate the protein extract. ATP, 
phosphocreatine and creatine kinase is added from a 20X stock, 
while CAB buffer is added from a 10X stock. The incubations are 
performed at 30°C for 1 to 2 hours. The reaction is stopped and 
the reaction products are isolated and analyzed as above, except 
the topoisomers are visualized by ethidium bromide staining.  
 
If removal of protein and RNA from the reaction is desired prior 
to gel analysis, RNase A and protease K are added as follows. 
The chromatin assembly reactions are stopped by the addition of 
10 µl of 2.5% Sarkosyl, 100 mM EDTA. Next, 1.0 µl of RNase 
A, from a 10 mg/ml stock (200 µg/ml final) is added, followed 
by a 15 minute incubation at 37°C. Following this, 5.0 µl of 
protease K from a 10 mg/ml stock (1 mg/ml final) is added, with 
a continued incubation at 37°C for 30 minutes. As above, 200 µl 
of stop buffer is added and the DNA is extracted and 
precipitated. 
 
In vivo chromatin assembly 
 
In vivo chromatin assembly assesses the degree of histone 
deposition onto the endogenous yeast 2µ plasmid (28, 29). 2µ 
plasmid DNA is isolated from 10 ml yeast cultures grown in the 
appropriate media, which is typically YPD. The 2µ plasmid is 
isolated by performing a standard “smash and grab” protocol. 
Briefly, cells from the 10 ml cultures are pelleted and resuspended 
in 200 µl SCE buffer (1 M Sorbitol, 100 mM NaPO4 pH 7.0 and 
60 mM EDTA) containing lyticase (10 mg lyticase/3 ml SCE; 
Sigma) to degrade the yeast cell wall. Zymolyase can be 
substituted for lyticase at equal quantities with similar results. The 
cells are then incubated on the bench top and checked for lysis 
every 15 minutes by mixing 5 µl of H2O with 2 µl of cells on a 
microscope slide. Typically, lysis requires 30-40 minutes. When 
the cells are lysed, 400 µl of lysis buffer (80 µl 10 N NaOH, 400 
µl 10% SDS and H2O up to 4 ml) is added and incubated on ice 
for 5 minutes. Next, 300 µl of 3M NaAc pH 4.8 is added and the 
tubes are incubated on ice for 5 minutes. The mixture is then 
centrifuged at 14,000 rpm for 5 minutes, with 600 µl of 
isopropanol added to the supernatant. A 10-minute incubation on 
ice follows. The tubes are then centrifuged for 10 minutes at 
14,000 rpm and the pellet is washed with 500 µl of 70% ethanol. 
Finally, the dried pellet is resuspended in 50 µl H2O. 
 
The 2µ plasmid topoisomers are separated through a large 0.8% 
agarose gel (13 x 25 cm; Owl) run at 70 V overnight in 1X TPE 
buffer (10X TPE: 108 g/L Tris base, 15.5 ml/L 85% phosphoric 
acid, 40 ml/L 0.5 M EDTA) in the dark. Chloroquine (20 mg/ml 
stock, stored in the dark, kept less than 4 weeks at 4°C; Sigma) is 
added to the running buffer and gel at concentrations ranging 
from 1.75-2.5 µg/ml. The appropriate concentration of 
chloroquine is determined qualitatively from observing the degree 
of negative supercoils resulting from a given concentration of 
chloroquine and adjusted in subsequent gels. Chloroquine loses 
its effectiveness over time. Therefore, fresh batches of stock 
chloroquine must be maintained. The 2µ topoisomers are 
observed by hybridizing 32P-labeled  REP1 DNA, which is 
encoded within the 2µ plasmid, to 2µ sequences transferred to 
nitrocellulose according to standard protocols (30). REP1 DNA 
is generated by PCR using the following primers: REP1-N: Harkness et al.    
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GCTAGAATTCGAGCTCATGAATGGCGAGACTGC;  REP1-C: 
GCTAGGTACCTCACCCATCCACCTTTCGCTC. The 
underlined sequence in the REP1-N primer defines EcoRI and 
SacI restriction sites, whereas the underlined sequence in the 
REP1-C primer defines a KpnI restriction site. These sites were 
included in the primers for cloning purposes. Loading of 2µ 
DNA is adjusted in subsequent gels according to visualization of 
2µ DNA. 
 
RESULTS AND DISCUSSION 
 
We have developed in vitro and in vivo methods for the study of 
chromatin assembly in yeast. As the basics of the in vitro and in 
vivo methods have been published previously (11, 28), the aim of 
this report is to describe modifications made to the methods that 
i) facilitate large-scale library screens, and ii) allow a much more 
rapid analysis. We will also describe mechanistic differences 
between the in vitro and in vivo methods that suggest alternative 
molecular control. 
 
Large-scale library screen for yeast chromatin 
assembly mutants using extracts prepared from 
kitchen coffee mills 
 
Protein extracts are prepared from yeast according to many 
different protocols. The majority of these methods are rapid and 
allow analysis of cellular proteins within hours by Western 
analysis (30). In our hands, methods that utilize glass beads or 
enzymatic breakage of the yeast cell wall to allow extraction of 
soluble proteins do not support in vitro chromatin assembly. The 
only method that we have found to extract whole cell proteins 
from yeast that will support in vitro chromatin assembly is by 
breakage of the cell wall in a kitchen coffee mill in the presence 
of dry ice. The key aspects of this protocol that must be strictly 
adhered to include: i) maintaining the yeast at or below 4°C at all 
times; ii) starting with at least 2 grams of pelleted cells; and iii) 
including a protease inhibitor cocktail in all washing and 
extraction buffers.  
 
Routinely, six yeast strains can be ground in coffee mills at one 
time. The limiting factor to the number of strains processed is 
the number of tubes that can be held in the ultracentrifuge rotor. 
If two ultracentrifuges are available, preparation of 12 extracts 
from 500 ml cultures is not overly cumbersome. However, if 
screening a library (usually a minimum of 100 extracts), daily 
preparation of 12 extracts may become onerous. As noted in the 
Materials and Methods, the frozen cell “noodles” can be made 
ahead of time and stored at -80° for an indefinite amount of 
time. If the approach is taken that all “noodles” are prepared 
ahead of time and frozen, six extracts can be prepared per day, 
totaling 30 per week. It is therefore possible to prepare 100 
extracts per month (not including the time required for "noodle" 
preparation). 
 
During the extract preparation, there are blocks of time required 
for centrifugation and dialysis. On a typical extraction day 
(assuming six extracts), approximately 60 to 90 minutes is 
required to prepare and grind the yeast “noodles,” thaw the 
broken yeast powder and to beginning ultracentrifugation. The 
ultracentrifuge spin is for 2 hours at 27,000 rpm (100,000 x g). 
Following the centrifuge spin, the extracts are dialyzed against a 
weak salt buffer. Setting up the dialysis requires approximately 30 
minutes and the dialysis is for 3 to 4 hours. Dispensing the 
resultant extract and flash freezing in liquid nitrogen will take 
approximately 30 minutes. Therefore, allow approximately 8 
hours to complete the preparation of six whole-cell extracts. If 
you desire to test the extracts for assembly activity as you go, 
there is plenty of time during the centrifuge spin and dialysis to 
conduct the chromatin assembly reactions. Figure 1 illustrates a 
typical assembly reaction using (γ-32P) ATP-labeled plasmid DNA 
from 18 extracts in which one extract was assembly defective. If 
“noodles” are prepared when needed, then 18 extracts per week 
(3 days of six extracts each) is achievable. The total time required 
for the experiment shown in Fig. 1 from seeding of original 10 ml 
cultures to developing the chromatin assembly autoradiogram 
was roughly 10 days. The characterization of the mutant extract 
shown in Fig. 1 was recently fully described (15). The mutant 
strain shown actually contained mutations in three genes: 
rmc1/apc5
CA, rmc2 and rmc3/rsp5
CA.  
 
Non-radioactive in vitro chromatin assembly  
 
The chromatin assembly assay used to generate Figure 1 has been 
described previously (11, 15). The complete experiment required 
approximately three days, which included running the gel 
overnight (for maximum separation of topoisomers) and 
exposure of the gel to film for an additional night. To speed up 
the process, we developed a non-radioactive in vitro chromatin 
assembly assay that can be completed in one day. The basic 
premise is identical to the radioactive assay: relaxed circular 
plasmid DNA is incubated with whole cell protein extract. More 
DNA is required (100 - 200 ng vs. 20 ng) for this reaction to 
allow visualization by ethidium bromide in an agarose gel. 150 ng 
of input plasmid gave the best ratio of intermediate to completely 
supercoiled product when incubated with 200 µg of protein 
extract (Fig. 2A). 
 
 
Fig. 2: Yeast whole-cell extracts support a rapid, non-radioactive in vitro 
chromatin assembly reaction. A. Increasing amounts of relaxed plasmid DNA Harkness et al.    
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were incubated with 200 µg of wild type (YTH1235) extract protein. The reaction 
proceeded for 1 hour at 30°C. The reaction products were then separated through 
a 1% agarose gel, stained with ethidium bromide, exposed to an ultraviolet (UV) 
radiation source and photographed. B. Increasing amounts of extract protein 
from wild type (YTH1235) and apc5CA (YTH1155) cells were incubated with 200 
ng of relaxed plasmid DNA. The apc5CA extract remained defective in this 
modified assay. C. A time course was established with a reaction containing 200 
ng of relaxed plasmid DNA and 200 µg of either wild type or apc5CA extract 
protein (strains were as described in Fig. 2B). Following the reaction, the plasmid 
DNA was precipitated and analyzed as described above. 
 
We also increased the amount of protein extract added to the 
reaction (200 - 300 µg vs. 50 - 100 µg) to compensate for the 
extra template DNA (Fig. 2B). In the experiment shown in Fig. 
2B, 200 µg of protein was sufficient to supercoil 200 ng of input 
plasmid. Increasing the amount of extract past 200 ng did not 
increase the supercoiling efficiency. The reaction requires 2 mM 
ATP (data not shown), an incubation time of up to three hours 
to completely assemble the input plasmid (Fig. 2C) and can be 
conducted in a single day. Yeast strains shown to be defective 
when using the radioactive assay (15) remain defective when 
using the rapid non-radioactive assay (apc5
CA lanes in Fig. 2B and 
2C). Therefore, use of the non-radioactive chromatin assembly 
assay when screening extracts for the purpose of identifying 
chromatin assembly impaired extracts greatly reduces the total 
time required for analysis. 
 
In vivo chromatin assembly 
 
To confirm that the in vitro chromatin assembly defects we 
observed reflected compromised in vivo chromatin metabolism, 
we took advantage of the supercoiling capacity of the yeast 
endogenous 2µ plasmid, demonstrated by Grunstein and 
colleagues (28, 29). To assess the supercoiling capacity of the 2µ 
p l a s m i d ,  w e  g r e w  c e l l s  i n  1 0  m l  o f  t h e  r e q u i r e d  m e d i a  a n d  
harvested the cells at mid log (OD600 1-3). Total DNA was then 
isolated according to standard protocols (29; see Materials and 
Methods for our modifications). Initially, 10 µg of total DNA 
was separated through a 0.8% agarose gel containing the 
intercalating agent, chloroquine. The amount of 2µ plasmid 
recovered varies between preparations and strains. Therefore, we 
generally adjust the load of DNA in subsequent runs. We use 2.0 
µg/ml chloroquine in the initial gels and running buffer and 
adjust accordingly afterwards in order to observe maximum 
supercoiling. 
 
The in vivo chromatin assembly activity depends on histones H3 
and H4. Our experiments demonstrated that 2µ plasmids isolated 
from cells where histones H3 and H4 were depleted have a 
reduced capacity to supercoil the 2µ plasmid (Fig. 3A). A strain 
containing deletions of the histone H3 and H4 encoding genes 
can be maintained by a plasmid expressing H3 and H4 from the 
GAL1/10 promoter. In the presence of galactose, histones H3 
and H4 are expressed. However, in the presence of glucose, the 
GAL1/10 promoter is repressed, resulting in the depletion of H3 
and H4 and a loss of 2µ supercoiling. This has been shown 
previously and serves as a control in our experiments (15, 29). 
Furthermore, we have previously shown that in vitro chromatin 
assembly is also compromised in these cells when grown in 
glucose (11). 
 
The in vitro and in vivo assembly assays define 
distinct assembly activities 
 
We next asked whether the similar histone dependence observed 
with the in vitro and in vivo assays reflected similar molecular 
mechanisms shared by the two activities. First, we determined the 
in vivo chromatin assembly profiles of two known in vitro 
chromatin assembly mutants, apc5
CA and rsp5
CA. We had already 
shown that the rsp5
CA mutant was indeed chromatin assembly 
defective  in vivo (15), but surprisingly, the apc5
CA mutant was 
completely wild type in this assay, even when the 2µ plasmid was 
extracted from cells grown at 37°C (Fig. 3B). This was the first 
indication that the two assays were fundamentally different. 
 
 
Fig. 3: An in vivo chromatin assembly assay assessing the supercoiling 
capacity of the yeast endogenous 2µ  plasmid. A. The in vivo assay is 
dependent upon histones. A plasmid encoding histone H3 and H4, under the 
control of the GAL1/10 promoter, was expressed in a strain harboring deletions 
of genes encoding histone H 3  a n d  H 4  ( R M Y 1 0 2 ;  a  g e n e r o u s  g i f t  f r o m  M .  
Grunstein). RMY102 was either grown in galactose to express H3 and H4, or 
grown in galactose and then shifted to glucose, which represses histone H3 and 
H4 synthesis, and therefore depletes histone H3 and H4. 2µ plasmids recovered 
from RMY102 grown under these conditions reveals a dependence on histones 
(compare the accumulation of intermediate topoisomers [int] in the – histone lane 
to the + histone lane). The 2µ plasmid was separated through an agarose gel 
containing 2.0 mg chloroquine and visualized using a Southern analysis with 32P 
labeled REP1 PCR products (see Materials and Methods). B. An apc5CA mutation, 
which confers in vitro chromatin assembly defects, has no effect on in vivo 
chromatin assembly. Isogenic wild type (YTH6) and apc5CA (YTH1155) cells were 
grown at 30°C and harvested, or shifted to 37°C, the apc5CA restrictive 
temperature, for an additional day of growth. 2µ plasmids were recovered and 
analyzed by agarose gel electrophoresis and Southern hybridization. RMY102 
cells, grown in galactose (+ histones) or glucose (- histones), were included as 
controls. The gel and buffer contained 2.5 µg/ml chloroquine in this experiment. 
 
With the knowledge that the two assays may indeed represent 
different activities, we next asked whether the two activities 
differed in response to cell cycle cues. The in vitro chromatin 
assembly activity is cell cycle dependent, with most activity 
occurring during mitosis (14, 15). To test whether the in vivo 
activity also relied on the cell cycle cues, we performed an 
arrest/release experiment with wild type cells. A fresh overnight Harkness et al.    
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culture was arrested with 300 mM hydroxyurea for 3 hours at 
room temperature. Since the cells used in this study expressed the 
wild type version of the Bar1p protease that degrades alpha 
factor, hydroxyurea was used, rather than alpha factor, to arrest 
the cells in G1. Hydroxyurea was then washed away and the cells 
were resuspended in fresh YPD media lacking hydroxyurea and 
the incubation was continued. Aliquots were removed after 60, 
90 and 120 minutes for FACS analysis and 2µ plasmid isolation. 
The FACS data demonstrated that the wild type cells re-entered 
the cell cycle (Fig. 4A). However, the 2µ plasmid assembly 
profiles showed that there was no significant difference in 
supercoiling capacity between plasmids isolated from G1/S or 
G2/M (compare lanes 3 with lanes 4 and 5 in Fig. 4B). 
 
 
Fig. 4: The in vivo chromatin assembly assay does not respond to cell cycle 
cues, unlike the mitotic specific in vitro assay. A. Wild type (YTH6) yeast 
cells were grown to mid log (OD600 of 1.0-1.5) and arrested in the G1 phase of 
the cell cycle by growth in the presence of 300 mM hydroxyurea for 3 hours. 
Following this treatment, the cells were washed with fresh YPD media, added 
back to hydroxyurea-free YPD and allowed to re-enter the cell cycle. Aliquots 
were removed at the indicated time points for FACS analysis and 2µ plasmid 
recovery. The FACS profiles demonstrated that the cells re-entered the cell cycle 
and resumed cycling. B. in vivo assembly analysis of the 2µ plasmid isolated from 
the cells described in part A. demonstrates that assembly of the 2µ plasmid does 
not depend on the phase of the cell cycle. 2µ plasmids were recovered as 
described above. The gel shown is a typical result; slight variations in the 2µ 
supercoiling capacity are often observed. This experiment contained 2.0 µg/ml 
chloroquine in the gel and buffers. 
 
Therefore, this analysis shows that the in vitro and in vivo assays 
respond to different signals within cells. This is also consistent 
with the observation that rsp5
CA, but not apc5
CA cells, are 
defective for in vivo chromatin assembly. The APC, of which 
Apc5p is a subunit, functions to ensure progression through, and 
exit from mitosis is unimpeded (24). Rsp5p, on the other hand, 
has many pleiotropic effects in the cell that do not depend on the 
cell cycle, such as endocytosis, nutrient sensing, mitochondrial 
biogenesis, signal transduction and RNA PolII-dependent 
transcription (21-23). Therefore, Rsp5p may be required to 
impinge upon both the cell cycle-independent in vivo chromatin 
assembly machinery and the mitotic in vitro chromatin assembly 
machinery, in order to carry out its many functions. 
 
CONCLUSIONS 
 
In this report we describe protocols designed to investigate 
chromatin assembly in the model system, Saccharomyces cerevisiae. 
An  in vitro chromatin assembly assay has been developed and 
utilized to screen yeast mutants for defects in chromatin 
assembly. This report describes modifications on the procedure 
first published in 1997 (11) that makes screening 100 extracts a 
manageable exercise. We also describe a rapid protocol to analyze 
extracts for in vitro activity without the use of radioactivity. 
Furthermore, we show the utility of an in vivo chromatin assembly 
assay, initially described by Grunstein and colleagues (28, 29), for 
further analysis of mutants defective for in vitro assembly. The 
results demonstrate that the two assays define separate chromatin 
assembly control networks that can be impinged upon by factors 
that can utilize one, or both activities. Thus, the tools described 
in this report enable factors involved in chromatin assembly 
throughout the cell cycle to be isolated via genetic screens and to 
be rigorously characterized. Indeed, we have found that mutants 
known to be defective for S phase coupled chromatin assembly, 
when in certain combinations, are compromised for in vitro 
chromatin assembly (Harkness and Arnason, unpublished data). 
Current efforts are aimed at determining whether the whole-cell 
extract preparation described here is amenable to systems other 
than yeast. 
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